biostudies-literatureSterlinski MBritish Heart FoundationBMS/Pfizer AllianceDaiichi Sankyo, and Boston ScientificBoehringer IngelheimBayerOxford National Institute for Health Research Biomedical Research CentreBirmingham British Heart Foundation Acceleratoreuae178https://www.ebi.ac.uk/biostudies/studies/S-EPMC11289729biostudies-literatureUnknown26(7)<h4>Aims</h4>The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) trial.<h4>Methods and results</h4>STEEER-AF is a pragmatic trial designed to objectively and robustly determine whether guidelines are adhered to in routine practice and evaluate a targeted educational programme for healthcare professionals. Seventy centres were randomized in six countries (France, Germany, Italy, Poland, Spain, and UK; 2022-23). The STEEER-AF centres recruited 1732 patients with a diagnosis of atrial fibrillation (AF), with a mean age of 68.9 years (SD 11.7), CHA2DS2-VEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of CardiologyDesign and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association.PMC11289729FS/CDRF/21/21032Kalla MGuy-Moyat BRoca Luque IMarijon ESinner MFDuncker DPiot OMerino JLFinlay MKotecha DMaury PDe Chillou CRaine DTDefaye PShin DICzerski TFernandez-Armenta JPavin DAnselme FGarcia-Izquierdo ECabanas PSobieszek GRajappan KGale CPSohaib ABorlich MSTEEER-AF Trial TeamDeneke TQureshi NWillems SThomas DAnguera IDohner WBuchta PAllali YMetzner ABaudinaud POsca JRapacciuolo AProietti MLovell MJPrice SHasni KSacher FLellouche NGajda RVan Gelder ICMazza ATubek SKirchhof PTilz RRCasadei BMont LRauch UVentura MStanbury MBanya WMobley APotpara TTrucco EBalsam PBunting KVChampsi AMehta SPadeletti MBoriani GSkrzynski ASHatala RBertini MCianci ACalvo NLyon ARGarcia RBates MGDAng RSun YHasan Bhuiyan ASterlinski MGuenancia CHeidbuchel HDavies MJSpitzer SGGminski WKBoveda SMorais SAABond RSommer PLobban TGuasch Evan Deutekom CGandjbakhch EFumagalli SKostkiewicz MPurerfellner HLica Gorzynska MGuerra JMBisbal FWilk-Manowiec HGreeley KKochhaeuser SIung BNordbeck PAcosta JValzania CBlicharz JLozano TLaredo MDiemberger IEscande WImberti JFPedersen MRobinson TSiong Ng FRusso VGorlo ARivas-Gandara NDe Guillebon MRaatikainen PGarnier FEbert HHfalseDesign and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association.<h4>Aims</h4>The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) trial.<h4>Methods and results</h4>STEEER-AF is a pragmatic trial designed to objectively and robustly determine whether guidelines are adhered to in routine practice and evaluate a targeted educational programme for healthcare professionals. Seventy centres were randomized in six countries (France, Germany, Italy, Poland, Spain, and UK; 2022-23). The STEEER-AF centres recruited 1732 patients with a diagnosis of atrial fibrillation (AF), with a mean age of 68.9 years (SD 11.7), CHA2DS2-V2024-01-01T00:00:00Z2024 Jul2026-06-02T22:07:04.698Z2025-05-29T19:05:25.443ZS-EPMC112897293894049410.1093/europace/euae178